Cargando…
How Do Pharmaceutical Companies Overcome a Corporate Productivity Crisis? Business Diversification into Medical Devices for Growth Potential
The purpose of this study was to analyze the performance of pharmaceutical companies’ business diversification into medical devices in terms of their technical efficiency (TE) as compared to that of traditional pharmaceutical companies. For a total of 174 externally audited pharmaceutical companies...
Autores principales: | Euh, Yoonje, Lee, Daeho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908371/ https://www.ncbi.nlm.nih.gov/pubmed/33503944 http://dx.doi.org/10.3390/ijerph18031045 |
Ejemplares similares
-
When companies spy on you: corporate data mining and big business
por: Miller, Caitlyn, et al.
Publicado: (2017) -
Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models
por: Ferrara, Joseph
Publicado: (2007) -
Public Health and Political Corporate Social Responsibility: Pharmaceutical Company Engagement in COVAX
por: Scholz, Markus, et al.
Publicado: (2023) -
Impact of Corporate Reputation on Brand Differentiation: An Empirical Study from Iranian Pharmaceutical Companies
por: vahabzadeh, Afshin, et al.
Publicado: (2017) -
Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market
por: Dănescu, Tatiana, et al.
Publicado: (2020)